Quantcast

Latest Rhinitis Stories

2009-11-27 03:49:00

PARIS, November 27 /PRNewswire-FirstCall/ -- Stallergenes has been granted European approval to market Oralair(R) in both adults and children through a Mutual Recognition Procedure. Germany, the first country where Oralair(R) has been marketed, was the reference Member state. Oralair(R) is now registered in Austria, Belgium, Bulgaria, Cyprus, the Czech Republic, Estonia, France, Germany, Greece, Hungary, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, the Netherlands, Poland,...

2009-11-20 03:00:00

OXFORD, England, November 20 /PRNewswire/ -- Circassia Ltd, a specialty biopharmaceutical company focused on allergy, today announced positive results from a recently completed phase II clinical study of its ToleroMune(R) cat allergy therapy, which successfully identified the optimal dosing regimens to progress into late-stage development. The clinical trial, which was the first of its kind in the field of cat allergy immunotherapy, showed that Circassia's ToleroMune treatment was...

2009-11-10 11:18:00

MADISON, Wis., Nov. 10 /PRNewswire/ -- In response to the study, "Long-term use of nasal saline irrigation: Harmful or helpful?", presented at the American College of Allergy, Asthma & Immunology Annual Meeting on November 8th, Diane G. Heatley, M.D., Associate Professor of Otolaryngology and Pediatrics at the University of Wisconsin School of Medicine and Public Health in Madison, WI, and the developer of the SinuCleanse® nasal wash system, issued the following...

2009-11-02 07:38:00

KENILWORTH, N.J., Nov. 2 /PRNewswire-FirstCall/ -- Schering-Plough Corporation (NYSE: SGP) today announced that its investigational sublingual Grass (Phleum Pratense) Allergy Immunotherapy Tablet (AIT) has met the primary endpoint in a Phase III study of adult subjects in the U.S. with a history of grass pollen induced rhinoconjunctivitis with or without asthma. The investigational Grass AIT treatment is designed to work by inducing a protective immune response against grass pollen allergy...

2009-10-16 08:14:43

Injecting botulinum toxin (botox) to treat intrinsic or allergic rhinitis may be a thing of the past as researchers have now shown that sponges soaked in botox are equally effective in treating the condition. The research published in BioMed Central's open access journal Head & Face Medicine offers a potential needle-free treatment to the millions of people who suffer from rhinitis. Rainer Laskawi (ENT-Department) worked with a team of researchers from the University Medical Center...

2009-10-15 14:00:00

Million EUR 2008 2009 09/08 EURm % Sales EURm % Sales Var.% Southern Europe (1) 23.8 70 26 68 9 Other EU countries (2) 8.6 25 10.3 27 20 Other markets 1.8 5 1.9 5 8 SLIT 26.3 77 30.5 79 16 SCIT 6.5...

2009-10-05 13:54:17

A comparison of symptoms in patients with allergic rhinitis (AR) and non-allergic rhinitis (NAR) revealed that those with the NAR experienced worse symptoms. The findings are according to new research presented at the 2009 American Academy of Otolaryngology-Head and Neck Surgery Foundation (AAO-HNSF) Annual Meeting & OTO EXPO, in San Diego, CA. The study assessed 78 patients with AR and 31 patients with non-allergic rhinitis (NAR), measuring quality of life (QOL) in both groups using a...

2009-10-05 06:10:00

Patients who suffer from both allergic rhinitis and obstructive sleep apnea (OSA) may experience escalated symptoms of stress and fatigue. In a paper presented at the 2009 American Academy of Otolaryngology "“ Head and Neck Surgery Foundation (AAO-HNSF) Annual Meeting & OTO EXPO in San Diego, researchers studied 34 people who were diagnosed with obstructive sleep apnea. Among them, 12 people were classified in the allergic rhinitis group and 22 people in the control group. The...

2009-10-02 06:17:00

WASHINGTON, Oct. 2 /PRNewswire/ -- The Asthma and Allergy Foundation of America (AAFA) announced today the 2009 Fall Allergy Capitals(TM) rankings. The annual research project ranks the fall's 100 most challenging cities for people with fall allergies. The top five cities this year are: McAllen, TX (1); Wichita, KS (2); Louisville, KY (3); Oklahoma City, OK (4); and Jackson, MS (5).(1) In addition, according to a recent AAFA survey, fall is also one of the most troublesome times of...

2009-09-16 12:14:00

ANTONY, France, September 16 /PRNewswire-FirstCall/ -- Stallergenes S.A. has announced the first results of a new phase IIb/III clinical trial (VO59.08) conducted in allergic rhinitis caused by birch pollen and concerning the development of a sublingual immunotherapy tablet containing the recombinant allergen of this pollen, rBet v 1. This study is the first ever to use a recombinant allergen as an active substance. To Stallergenes' knowledge, the use of a recombinant protein in dry...


Word of the Day
cenobite
  • One of a religious order living in a convent or in community; a monk: opposed to anchoret or hermit (one who lives in solitude).
  • A social bee.
This word comes from the Latin 'coenobium,' convent, which comes from the Greek 'koinobios,' living in community.
Related